artivabio.com - ARTV Operating profit EBITDA

Brandmark of Artiva Biotherapeutics (ARTV)

Clinical trial risks for allogeneic NK therapies remain the primary volatility driver, as confirmed by the EBITDA trend visualization. Artiva Biotherapeutics, Inc. (ARTV) is developing breakthrough treatments for solid tumors, and the absence of side effects provides an opportunity for monopoly pricing power. Meanwhile, the 0.00 indicator determines the absolute operating profit metric, helping to avoid overpaying for the asset during a recession.

ARTV - Artiva Biotherapeutics Operating profit EBITDA over the range 11/23/2025 - 11/18/2026

Summary analytical data breakdowns for Artiva Biotherapeutics, Inc. (ARTV)

- current quotes and average value forecast:
Fundamental company valuation:artivabio.com ARTV
Original product of Artiva

This indicator measures net cash flow from operating activities before depreciation, interest, and taxes, demonstrating the business's actual ability to generate internal resources. An analysis of aggregated EBITDA allows for an assessment of the financial stability of Artiva Biotherapeutics, Inc. (ARTV) during the development of affordable NK-cell therapies, where earnings volatility directly reflects the cost of innovative research and the operational risks of high-tech manufacturing.

Who Artiva Biotherapeutics, Inc. competes with

Operating profit EBITDA beigene.com ONC|HALO: Operating profit before deduction of amortization|RVMD - Operating profit EBITDA|Ascentage (AAPG) - Profit before payment of interest, taxes and amortization|CG Oncology Corp - Income before deduction of interest, taxes and amortization|URGN (UroGen Pharma Ltd) - Operating profit EBITDA|Profit before interest, taxes and amortization Bicara Therapeutics Inc. BCAX|Profit before payment of interest, taxes and amortization Personalis, Inc. (PSNL)|ERAS - Profit before interest, taxes and amortization|Operating profit EBITDA DCTH (delcath.com)|Operating profit before depreciation charges Y-mAbs Corp|AURA - Profit before payment of interest, taxes and amortization|CADL (candeltx.com) - Operating profit before amortization|ARAY (accuray.com) - Operating profit before deduction of amortization|SELLAS Life Sciences Group Inc. (SLS) - Operating profit EBITDA|ACTU (Actuate Therapeutics Inc.) - Operating profit EBITDA|Operating profit EBITDA Citius Oncology Inc|Operating profit EBITDA HURA|TARA (Protara Therapeutics) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA FATE (Fate Therapeutics)|Operating income before deduction of amortization Aadi Bioscience Inc (WHWK)|TScan Therapeutics, Inc. - Operating profit EBITDA|CSBR (Champions Oncology, Inc.) - Operating profit before amortization|XBIT (XBiotech USA) - Operating profit before deduction of amortization|Profit before interest, taxes and amortization CEL-SCI Corp (CVM)|OSTX (OS Therapies Inc.) - Operating profit EBITDA|Operating profit before deduction of amortization Radiopharm Theranostics (RADX)|Operating profit EBITDA ANL|VERU - Profit before interest, taxes and amortization|Profit before payment of interest, taxes and amortization Tempest Therapeutics TPST|xiliotx.com (XLO) - Profit before interest, taxes and amortization|RENB: Operating profit before deduction of amortization|Operating profit before depreciation charges Mural Oncology PLC (MURA)|KAPA (Kairos Pharma Inc) - Operating profit before deduction of amortization|Profit before interest, taxes and amortization OnKure Therapeutics Inc (OKUR)|GDTC (CytoMed Therapeutics Ltd) - Operating profit EBITDA|Operating profit before deduction of amortization Curis, Inc. (CRIS)|Operating profit EBITDA APLM|Company profit before taxes, interest and amortization THAR|Operating profit EBITDA ADVB (advanbiomed.com)|GNPX - Operating profit before deduction of amortization|CLDI: Operating profit before deduction of amortization|SBFM - Operating profit EBITDA|Xenetic Biosciences (XBIO) - Profit before payment of interest, taxes and amortization|SLRX: Company profit before taxes, interest and amortization|PPBT (Purple Biotech Ltd) - Operating profit EBITDA|Profit before interest, taxes and amortization American Oncology Network, Inc. AONC|Operating profit EBITDA BGNE|Operating income before deduction of amortization Checkpoint Therapeutics|Elevation Oncology, Inc. - Operating profit before deduction of amortization|Operating profit EBITDA iCAD, Inc. ICAD|Ikena Oncology, Inc. - Operating profit EBITDA|NTBL - Operating profit EBITDA|VIRX (Viracta Therapeutics) - Operating profit before deduction of amortization|MorphoSys AG - Income before deduction of interest, taxes and amortization|NAYA (NAYA Biosciences Corp) - Operating profit EBITDA|Operating profit EBITDA Ascentage Pharma Group International